Charles River’s $1B revenue; Theratechnologies restarts HIV drug supply

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Charles River Laboratories’ stock {$CRL} was up 7% on Wednesday after beating Wall Street estimates for ...

Related Posts

FDA says Ozempic, Wegovy shortage is over

Feb 21, 2025  0

Eli Lilly stockpiles $548M of oral weight loss drug ahe...

Feb 21, 2025  0

Roche unveils plans for its DNA sequencer that's been 1...

Feb 20, 2025  0

Comments

Name

Email

Comment

Post Comment